Roche Holding's chairman criticizes industrial subsidies as wasteful, advocating for fair competition and government ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

SOUTH SAN FRANCISCO, Calif., September 19, 2024--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results of the Phase III CENTERSTONE study of ...

Roche's phase 3 CENTERSTONE study shows Xofluza (baloxavir marboxil) significantly reduces influenza transmission in ...

In a report released today, Luisa Hector from Berenberg Bank maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with ...

Based on these metrics and many more, RHHBY holds a Value grade of B, while ABBV has a Value grade of C. RHHBY sticks out from ABBV in both our Zacks Rank and Style Scores models, so value investors ...

Designed to provide broad exposure to the Broad Developed World ETFs category of the market, the SPDR MSCI EAFE StrategicFactors ETF (QEFA) is a smart beta exchange traded fund launched on 06/04/2014.

AstraZeneca Plc and Daiichi's breast cancer drug Enhertu is based off of Daiichi's antibody-drug conjugate platform DXd, and ...

The FDA has approved Roche's Ocrevus Zunovo for relapsing and primary progressive multiple sclerosis, offering the first ...

In a report released today, Matthew Weston from UBS maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with a price ...

Fulcrum Therapeutics, Inc. stock plunged 60% as lead candidate failed its Phase 3 trial. Is this a contrarian opportunity?

European stocks gain after the European Central Bank delivered an interest rate cut that was in-line with expectations.